{"store":{"baseInfo":{"podcastTitle":"PALTtalk","slug":"palttalk","podcastDescription":"Effective August 13, 2024, AMDA On-The-Go and all affiliate podcasts will now go by PALTtalk.\n\nExplore the field of post-acute and long-term care, with expert interviews, journal article reviews, innovations news, and more. \n\nStatements made by guests on this podcast are their own opinions and are not necessarily the positions of the assocation. Speakers’ appearance on the program does not imply an endorsement of them, their views, or any entity they represent.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/2284468/PALTtalk_Logobkzt7.png","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/2284468/PALTtalk_Logobkzt7_1200x628.jpg?s=a579ee4eedf9f3d40c7b3a5e4711daf2&e=png","podcastUrl":"https://palttalk.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/palttalk/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-w5q4e-22dbb4","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":15,"gmtAdjustment":"GMT-05:00","useDaylightTime":1,"value":-5,"text":"(GMT-05:00) Eastern Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/New_York"},"podcastDownloads":null,"totalEpisodes":312,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Post-Acute and Long-Term Care Medical Association","engagementStatsBaseUrl":"https://d1.podbean.com/webplayer_engagement?u=67d1236561ed277d7f08ccce","shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-w5q4e-22dbb4-playlist","language":"en","sensitivitySessionExpireTime":900,"podcastApps":[{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fpalttalk.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog2284468%26podcastIdTag%3Dw5q4e&dfl=https%3A%2F%2Fpalttalk.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/7yFZ70wiGv6JrYZL1NRGPO","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Geometric Humanist"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/Kz263hYAfpw","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-WjaMWI0puz9","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer1"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2023 AMDA. All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":["(function(i,s,o,g,r,a,m){i[\"GoogleAnalyticsObject\"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,\"script\",\"https://www.google-analytics.com/analytics.js\",\"ga\");ga(\"create\", \"UA-42900554-1\", {\"cookieDomain\":\"auto\",\"allowLinker\":true});ga(\"require\", \"linker\");ga(\"linker:autoLink\", [\"https:\\/\\/paltc.digitellinc.com\",\"https:\\/\\/www.eventscribe.com\",\"https:\\/\\/profile.paltc.org\\/\",\"https:\\/\\/apex.paltc.org\"]);ga(\"set\", \"anonymizeIp\", true);ga(\"send\", \"pageview\");"],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://palttalk.podbean.com","apiCommonParams":{"t":"67d12365","clientSignature":"7bd326efc8944bd2a4f9b4c0c9941f36","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb17237880-23bqp","episode":{"id":"pb17237880","idTag":"23bqp","title":"CMDA | Aducanumab","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog2284468/amda_geriatric_journal_transp_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog2284468/amda_geriatric_journal_transp_1200x628.jpg?s=721f82499299c08aa9da37f61208a529&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog2284468/amda_geriatric_journal_transp.png","previewContent":null,"content":"

Dr. Lea Watson covers two drugs, Nuplazid and the new one approved by the FDA, Aducanumab. Followed by Dr. Sing Palat, CMD and new President of CMDA who discusses the use of oxygen with nocturnal hypoxemia in COPD.

Recording Date: 5/6/2021

Available Credit

0.25 CMD-Clinical

","publishTimestamp":1624641908,"duration":1584,"mediaUrl":"https://mcdn.podbean.com/mf/web/h6v7i7/cmdamay2021leawatkins.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-23bqp-1070778","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-23bqp-1070778","transcriptUrl":null,"permalink":"/e/cmda-aducanumab/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB107077823BQP","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":1166,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-23bqp-1070778","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb17237880","idTag":"23bqp","title":"CMDA | Aducanumab","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog2284468/amda_geriatric_journal_transp_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog2284468/amda_geriatric_journal_transp_1200x628.jpg?s=721f82499299c08aa9da37f61208a529&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog2284468/amda_geriatric_journal_transp.png","previewContent":null,"content":"

Recording Date: 5/6/2021

Available Credit

0.25 CMD-Clinical

CMDA | Aducanumab

Comments (0)